(0.10%) 5 105.20 points
(0.19%) 38 313 points
(0.13%) 15 948 points
(-1.44%) $82.64
(5.77%) $2.03
(0.32%) $2 354.60
(-0.19%) $27.48
(3.90%) $958.05
(-0.19%) $0.933
(-0.33%) $10.99
(-0.50%) $0.796
(1.68%) $93.42
-1.52% INR 106.95
Live Chart Being Loaded With Signals
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally...
Stats | |
---|---|
Dagens volum | 234 440 |
Gjennomsnittsvolum | 1.03M |
Markedsverdi | 17.91B |
EPS | INR0 ( 2024-02-09 ) |
Neste inntjeningsdato | ( INR0 ) 2024-05-20 |
Last Dividend | INR0.450 ( 2016-07-28 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -465.00 |
ATR14 | INR0.117 (0.11%) |
Volum Korrelasjon
Camlin Fine Sciences Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
CENTUM.NS | 0.816 |
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Camlin Fine Sciences Korrelasjon - Valuta/Råvare
Camlin Fine Sciences Økonomi
Annual | 2022 |
Omsetning: | INR16.82B |
Bruttogevinst: | INR8.68B (51.64 %) |
EPS: | INR3.11 |
FY | 2022 |
Omsetning: | INR16.82B |
Bruttogevinst: | INR8.68B (51.64 %) |
EPS: | INR3.11 |
FY | 2022 |
Omsetning: | INR14.09B |
Bruttogevinst: | INR6.40B (45.43 %) |
EPS: | INR4.65 |
FY | 2021 |
Omsetning: | INR11.81B |
Bruttogevinst: | INR5.86B (49.64 %) |
EPS: | INR4.13 |
Financial Reports:
No articles found.
Camlin Fine Sciences Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR0.450 | 2015-07-27 |
Last Dividend | INR0.450 | 2016-07-28 |
Next Dividend | INR0 | N/A |
Payout Date | 2016-09-10 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | INR0.900 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.84 | -- |
Div. Sustainability Score | 0.424 | |
Div.Growth Potential Score | 1.741 | |
Div. Directional Score | 1.082 | -- |
Year | Amount | Yield |
---|---|---|
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0 | 0.00% |
2019 | INR0 | 0.00% |
2020 | INR0 | 0.00% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SUNPHARMA.NS | Dividend Junior | 2023-07-28 | Semi-Annually | 29 | 0.77% | |
NAVA.NS | Dividend Knight | 2023-07-24 | Annually | 23 | 2.35% | |
HONAUT.NS | Dividend Junior | 2023-08-03 | Annually | 21 | 0.15% | |
CARBORUNIV.NS | Dividend Junior | 2023-07-25 | Semi-Annually | 23 | 0.33% | |
ROHLTD.NS | Dividend Junior | 2023-09-15 | Sporadic | 19 | 0.20% | |
LAURUSLABS.NS | Dividend Knight | 2023-05-10 | Semi-Annually | 8 | 0.35% | |
FOSECOIND.NS | Dividend Knight | 2023-05-17 | Annually | 22 | 0.68% | |
APOLLO.NS | Dividend Junior | 2023-09-22 | Annually | 7 | 0.79% | |
TCI.NS | Dividend Junior | 2023-07-25 | Semi-Annually | 23 | 0.70% | |
OBEROIRLTY.NS | Dividend Junior | 2023-06-21 | Sporadic | 14 | 0.19% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.00394 | 1.500 | -0.0788 | -0.118 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.00732 | 1.500 | -1.192 | -1.789 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.418 | 1.000 | -0.586 | -0.586 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.14 | 2.00 | 6.43 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.473 | 1.000 | 5.45 | 5.45 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0248 | 1.000 | -1.504 | -1.504 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 0.424 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -280.63 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.00732 | 2.50 | -0.767 | -1.789 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 8.47 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0729 | 1.000 | -0.677 | 0 | [0.1 - 0.5] |
Total Score | 1.741 |
Camlin Fine Sciences
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as natural antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; and nutraceutical products from fermentation and plant extraction sources. In addition, it offers performance chemicals, such as hydroquinone and catechol; and downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, HQEE, etc. The company also exports its products. Its products are used in food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemical, agrochemical, pharmaceutical, polymers, dyes and pigment, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplement industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.